Publications

Find at Harvard

Register to Read

15 May 2017
Blog Post

Exploring Career Options at HBS

future is to launch and/or grow a business that helps people live healthier lives. I spent the summer at McKinsey in New York, with a hope to get exposure to different industries and function areas, as well as to expand my network in the... View Details

October 2016 (Revised November 2016)
Case

Innovating Beyond Ochsner

By: Richard G. Hamermesh and Olivia Hull

The Ochsner Health System has developed a proprietary software tool designed to treat hypertension. Built into the system’s electronic medical records, the Hypertension Digital Medicine program allows patients to record their blood pressure at home and share readings... View Details

25 Apr 2005
Research & Ideas

New Learning at American Home Products

pharmaceuticals, it concentrated on enlarging its OTC business by, as before, exploiting its advertising skills. By 1979 it had developed a broader line of new prescription drugs, beginning in 1968 with Inderal, a beta-blocker drug licensed from Imperial Chemical View Details

Keywords: by Alfred D. Chandler Jr.; Chemical; Health; Manufacturing; Pharmaceutical

Career Coach

Suzie Rubin

Suzie's (Kellogg '94) works with students and young alumni who have a wide variety of backgrounds and interests, both career switchers and those looking to advance within a given industry or function. She coaches students to think through... View Details

Keywords: Health Care

December 2024
Case

Blue Cross Blue Shield of Michigan (BCBSM): The AI Journey

By: Shikhar Ghosh

In early 2024, Bill Fandrich, Executive VP and CIO of Blue Cross Blue Shield of Michigan (BCBSM), faced a critical decision about AI adoption within the organization. Fandrich had championed AI implementation at BCBSM. After successfully developing three AI... View Details

William C. Kirby is T. M. Chang Professor of China Studies at Harvard University and Spangler Family Professor of Business Administration at the Harvard Business School. He is a Harvard University Distinguished Service Professor. He serves as Chairman of the Harvard... View Details

Keywords: education industry; education industry

September 2014 (Revised May 2017)
Case

Fresno's Social Impact Bond for Asthma

By: John A. Quelch and Margaret L. Rodriguez

In 2014, Social Impact Bonds (SIBs) were quickly gaining popularity as an investment vehicle which joined together private investors and nonprofits to tackle social issues. Although numerous SIB projects and proposals had cropped up across the U.S. following the launch... View Details

Keywords: Social Enterprise; Health Care; Marketing; Bonds; Financing; Asthma; Air Pollution; Air Quality; Chronic Disease; Public Health; Health; Health Care and Treatment; Finance; Health Industry; Health Industry; United States

Article

A Blueprint for Pharmacy Benefits Managers to Increase Value

By: William Shrank, Michael E. Porter, Sachin H. Jain and Niteesh K. Choudhary

Pharmacy benefits managers (PBMs) have a unique opportunity to promote public health and generate value in the healthcare system. However, PBMs are largely evaluated on their ability to control costs rather than improve health. PBMs should be evaluated along three... View Details

Keywords: Opportunities; Health; System; Cost Management; Partners and Partnerships; Motivation and Incentives; Value; Innovation and Invention; Performance Effectiveness; Health Industry; Health Industry

Find at Harvard

September 2023
Article

The Health Costs of Dirty Energy: Evidence from the Capacity Market in Colombia

By: Achyuta Adhvaryu, Theresa Molina, Anant Nyshadham, Jorge Tamayo and Nicholas Torres

The health effects of “dirty” (fossil fuel driven) energy production are difficult to measure accurately due to the endogeneity of fuel choice. We exploit an electricity policy in Colombia that generates a price-based trigger for the use of thermal energy sources.... View Details

Keywords: Pollution; Health Disorders; Energy Industry; Colombia

Read Now

December 2018
Case

Corporate Transformation at Merck KGaA, Darmstadt, Germany

By: Joseph B. Fuller, Amy C. Edmondson, Daniela Beyersdorfer and Tonia Labruyere

When Stefan Oschmann became CEO and chairman of the executive board of Merck KGaA, Darmstadt, Germany, in 2016, the company had started its transformation from a mid-tier traditional German industry player to a global modern science and technology player. The... View Details

Keywords: Corporate Governance With Family Ownership; Transformation; Change Management; Restructuring; Corporate Governance; Family Ownership

02 Apr 2015
Research & Ideas

Digital Initiative Summit: Freeing Patient Data to Enable Innovation

discussion, along with Dr. Maulik Majmudar, a former cardiologist and now associate director of the Healthcare Transformation Lab at Massachusetts General Hospital and chief clinical officer and founder of Quanttus, and Corbin Petro,... View Details

Keywords: Re: Karim R. Lakhani; Health

Web

PhD Programs - Doctoral

healthcare industry, while others arrive at the program with a background in disciplinary research The PhD program in Organizational Behavior offers two tracks: either a micro or macro approach. In the micro track, students focus on the... View Details

Web

Faculty & Advisors | MBA

to him joining Centerview, Mark was responsible for the global healthcare investment banking practice at Merrill Lynch. During his tenure, Merrill Lynch was the leading equity financier for the biotechnology industry. Additionally, he... View Details

Career Coach

Liuna Fekravar

internship at Carlyle in its special situations credit investing team. She spent this past summer interning with Lindsay Goldberg in NYC, driven by a motivation to pivot into a generalist buyout role where she could also exercise her passion for View Details

September 2016
Case

Health Leads: Reaching for Impact (Abridged)

By: V. Kasturi Rangan and Sarah Appleby

A nonprofit in the healthcare arena explores strategies to achieve system-level impact. Founded in 1996 with a volunteer-staffed help desk at Boston Medical Center connecting low-income patients with basic resources like heating assistance, job training, and childcare... View Details

Keywords: Scaling Social Enterprise; Scaling Social Impact; Health Care Delivery; Health Care Outcomes; Health Care Reform; Nonprofit; Nonprofit Scaling; Social Enterprise; Health Care and Treatment; Nonprofit Organizations; Growth and Development Strategy; Health Industry; United States

March 2016
Case

Residency Select or J3Personica?

By: William Kerr and Kathryn S. Roloff

Residency Select, LLC provides psychometric assessments for matching medical students to residency programs. After a series of successful pilots, founder Alan Friedman is considering whether to continue developing his offerings in this area, or whether to expand into... View Details

Keywords: Marketplace Matching; Expansion; Higher Education; Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Service Industry

December 2006 (Revised October 2016)
Case

eClinicalWorks: The Paths to Growth

By: Robert F. Higgins and Mark Rennella

In January 2006, eClinicalWorks (eCW) had an acquisition opportunity that could fundamentally change the way they had done business since the inception of the company in 1999. eClinicalWorks was a privately run business in the healthcare information technology field... View Details

Keywords: Young Companies; Strategic Revelation; Strategy And Execution; Strategy Development; Strategy And Leadership; Financing Strategy; Financing Risk; Financing; Expansion; Business Growth and Maturation; Organizational Culture; Financing and Loans; Customer Focus and Relationships; Acquisition; Growth and Development Strategy; Information Technology Industry; Information Technology Industry; Massachusetts

June 2012
Case

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships

By: Arthur A. Daemmrich and Ian McKown Cornell

Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details

Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Biotechnology Industry; Biotechnology Industry; Brazil

April 12, 2022
Article

Evaluation of Individual and Ensemble Probabilistic Forecasts of COVID-19 Mortality in the United States

By: Estee Y. Cramer, Evan L. Ray, Velma K. Lopez, Johannes Bracher, Andrea Brennen, Alvaro J. Castro Rivadeneira, Michael Lingzhi Li and et al.

Short-term probabilistic forecasts of the trajectory of the COVID-19 pandemic in the United States have served as a visible and important communication channel between the scientific modeling community and both the general public and decision-makers. Forecasting models... View Details

Keywords: COVID-19; Forecasting and Prediction; Health Pandemics; Mathematical Methods; Partners and Partnerships